Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,776 | 348 | 98.0% |
| Education | $136.00 | 9 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,633 | 102 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,360 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $926.20 | 49 | $0 (2024) |
| Amgen Inc. | $272.44 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $212.84 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $210.92 | 13 | $0 (2024) |
| Philips Electronics North America Corporation | $210.81 | 13 | $0 (2023) |
| GENZYME CORPORATION | $198.88 | 6 | $0 (2024) |
| United Therapeutics Corporation | $171.89 | 9 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $168.69 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,454 | 54 | AstraZeneca Pharmaceuticals LP ($493.89) |
| 2023 | $1,024 | 56 | AstraZeneca Pharmaceuticals LP ($251.55) |
| 2022 | $1,329 | 71 | GlaxoSmithKline, LLC. ($263.82) |
| 2021 | $1,166 | 59 | GlaxoSmithKline, LLC. ($327.43) |
| 2020 | $141.60 | 10 | Philips Electronics North America Corporation ($30.98) |
| 2019 | $446.06 | 29 | GlaxoSmithKline, LLC. ($99.86) |
| 2018 | $412.86 | 30 | GlaxoSmithKline, LLC. ($123.83) |
| 2017 | $938.96 | 48 | GlaxoSmithKline, LLC. ($242.11) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $117.66 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $40.47 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Immunology | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 797 | 1,375 | $664,458 | $142,575 |
| 2022 | 12 | 767 | 1,394 | $737,190 | $159,877 |
| 2021 | 13 | 947 | 1,897 | $924,440 | $207,037 |
| 2020 | 13 | 838 | 1,773 | $956,925 | $213,823 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 154 | 374 | $350,085 | $68,725 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 341 | $105,215 | $24,802 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 100 | 249 | $61,040 | $16,751 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 59 | $36,670 | $8,764 | 23.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 85 | $28,860 | $8,708 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $31,560 | $7,701 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $11,295 | $2,628 | 23.3% |
| 32554 | Aspiration of fluid from chest cavity | Facility | 2023 | 16 | 24 | $25,068 | $2,244 | 9.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 12 | $9,210 | $868.32 | 9.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 48 | 48 | $1,920 | $493.44 | 25.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 48 | 48 | $1,440 | $366.24 | 25.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 37 | 37 | $1,295 | $325.97 | 25.2% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 16 | 16 | $800.00 | $197.60 | 24.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 186 | 423 | $395,610 | $78,709 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 233 | $72,170 | $18,223 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 85 | 240 | $56,145 | $14,558 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 160 | $53,590 | $14,315 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 143 | $61,975 | $14,169 | 22.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $36,890 | $9,623 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $28,205 | $7,153 | 25.4% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 19 | 20 | $15,450 | $1,411 | 9.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 17 | 17 | $15,370 | $1,251 | 8.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 16 | 17 | $680.00 | $178.65 | 26.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 16 | 17 | $595.00 | $153.21 | 25.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 16 | 17 | $510.00 | $132.73 | 26.0% |
About Dr. Sean Sadikot, M.D
Dr. Sean Sadikot, M.D is a Pulmonary Disease healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003075110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Sadikot, M.D has received a total of $6,912 in payments from pharmaceutical and medical device companies, with $1,454 received in 2024. These payments were reported across 357 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,776).
As a Medicare-enrolled provider, Sadikot has provided services to 3,349 Medicare beneficiaries, totaling 6,439 services with total Medicare billing of $723,312. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Hackensack, NJ
- Active Since 06/03/2008
- Last Updated 10/29/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003075110
Products in Payments
- NUCALA (Biological) $765.98
- TEZSPIRE (Biological) $541.25
- FASENRA (Biological) $438.88
- TRELEGY ELLIPTA (Drug) $434.40
- OFEV (Drug) $370.84
- DUPIXENT (Biological) $296.95
- STIOLTO RESPIMAT (Drug) $269.76
- ANORO (Drug) $195.30
- (8874) inCourage (Device) $178.33
- TYVASO (Drug) $171.89
- BREO (Drug) $167.05
- BREZTRI (Drug) $162.41
- CHARTIS CATHETER (Device) $145.83
- NUZYRA (Drug) $139.46
- SOLIRIS (Drug) $129.77
- SYMBICORT (Drug) $127.44
- YUPELRI (Drug) $126.44
- BEVESPI AEROSPHERE (Drug) $123.13
- STIOLTO (Drug) $119.68
- GLASSIA (Biological) $92.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hackensack
Dr. Emanuele Santomauro, Md, MD
Pulmonary Disease — Payments: $383,229
Dr. Nadeem Ali, M.d, M.D
Pulmonary Disease — Payments: $65,634
Dr. David Orr, Do, DO
Pulmonary Disease — Payments: $14,176
Dr. John Villa, Do, DO
Pulmonary Disease — Payments: $14,032
Dr. Keith Rose, M.d, M.D
Pulmonary Disease — Payments: $12,026
Dr. Keith Brenner, M.d, M.D
Pulmonary Disease — Payments: $4,454